
Carpal tunnel syndrome treatment in Bellingham, WA
Waking up with numb hands, dropping objects, or losing grip strength — carpal tunnel syndrome compresses the median nerve at the wrist. Dr. Borys offers ultrasound-guided nerve hydrodissection as a non-surgical option supported by multiple randomized trials.
Book an initial visitMedian nerve compression at the wrist
The carpal tunnel is a narrow channel at the base of the wrist formed by the carpal bones and the transverse carpal ligament. The median nerve passes through this tunnel alongside the flexor tendons of the hand. When pressure inside the tunnel increases — from tendon swelling, repetitive loading, fluid retention, or anatomical factors — the median nerve becomes compressed and begins to signal abnormally.
The result is the characteristic symptom pattern: numbness and tingling in the thumb, index, middle, and part of the ring finger; symptoms that are worse at night or with sustained wrist positions; and, in more advanced cases, weakness and wasting of the thenar muscles at the base of the thumb.
Carpal tunnel syndrome is the most common peripheral nerve entrapment. It is more prevalent in women, in people over 40, in those with diabetes or thyroid disorders, and in occupations involving sustained wrist flexion or repetitive hand use.
Ultrasound-guided dextrose hydrodissection for carpal tunnel syndrome has support from multiple randomized controlled trials, with improvements in symptom severity and hand function measured at six months. A 2023 systematic review and meta-analysis supported ultrasound-guided perineural injection. Longer-term results are less certain: a 2026 trial found benefit fading over 12 months and outcomes comparable to corticosteroid, and the American Academy of Orthopaedic Surgeons' 2024 guideline rates the long-term evidence as limited. A retrospective study also supports hydrodissection for persistent symptoms after surgical release.
Why patients consider this
- Numbness and tingling that wakes you at night or persists through the day
- Grip weakness making it difficult to open jars, hold a phone, or type for extended periods
- Had a cortisone injection that helped temporarily but symptoms have returned, or have not responded to conservative care at all
- Want to know exactly what is happening at the wrist before any treatment is offered
Can carpal tunnel syndrome improve without surgery?
Often, yes, particularly when symptoms are mild to moderate and there are no signs of significant nerve damage. Nighttime wrist splinting, modifying activities that aggravate symptoms, and addressing contributing medical conditions are common first steps. Corticosteroid injections can also provide temporary relief.
For symptoms that persist despite conservative treatment, ultrasound-guided nerve hydrodissection may be an option for selected patients with mild-to-moderate carpal tunnel syndrome. It has not been established as a replacement for surgical release.
Constant numbness, progressive hand weakness, or wasting of the muscles at the base of the thumb may indicate more advanced nerve injury. These symptoms warrant prompt evaluation, as surgical release may be necessary to prevent permanent nerve damage.
How Dr. Borys approaches carpal tunnel syndrome
Treatment begins with identifying the source and severity of median nerve compression. For persistent symptoms that have not responded to conservative care, Dr. Borys may consider ultrasound-guided hydrodissection, with perineural injection therapy as an adjunct when nerve-driven pain extends up the forearm. Other treatment options or surgical referral are recommended when appropriate.
Nerve hydrodissection
Primary approachUltrasound-guided injection of a buffered 5% dextrose solution around the median nerve at the carpal tunnel separates the nerve from surrounding tissue planes. Used for persistent mild-to-moderate carpal tunnel syndrome that has not settled with splinting and activity changes.
Learn more about nerve hydrodissectionPerineural injection therapy
Small amounts of low-concentration dextrose injected at intervals along the median nerve to settle nerve-driven aching or burning that extends up the forearm beyond the typical carpal tunnel distribution. Used as an adjunct to hydrodissection when proximal symptoms are present.
Learn more about perineural injection therapyWho tends to benefit — and who does not
Hydrodissection tends to be a reasonable option for people who:
- Have confirmed or clinically suspected carpal tunnel syndrome based on symptoms and exam
- Have persistent numbness, tingling, or weakness that has not resolved with splinting or a cortisone injection
- Want a non-surgical option before committing to open or endoscopic carpal tunnel release
- Have had carpal tunnel surgery but continue to have symptoms — limited clinical evidence suggests hydrodissection may help in selected cases
It is less likely to be the right starting point for people who:
- Have early or mild symptoms that may still respond to consistent splinting and activity modification alone
- Have severe thenar muscle wasting suggesting advanced axonal loss — surgical release is generally the better option at that stage
- Have a different diagnosis causing hand symptoms — cervical radiculopathy, thoracic outlet, and pronator syndrome can mimic CTS closely, and examination will clarify this
Whether hydrodissection is appropriate depends on the duration and severity of your symptoms, prior treatment history, and findings on exam and ultrasound. Dr. Borys will review all of this at the initial visit.
Ready for a closer look at what may be driving your pain?
You are not signing up for a procedure. The first visit is a medical evaluation: history, exam, imaging review when relevant, and a clear recommendation — whether that is regenerative care, rehab, referral, or watchful waiting.
What the research shows
Randomized trials, a systematic review, and a retrospective study of dextrose hydrodissection in carpal tunnel syndrome are summarized below.
Ultrasound-guided perineural injection for carpal tunnel syndrome
Systematic review and meta-analysis (Lam et al., Diagnostics 2023) pooled 20 controlled trials of ultrasound-guided interventions for CTS. 5% dextrose injection outperformed control injections, high-volume dextrose hydrodissection outperformed low-volume, and no serious adverse events were reported. The authors called for more head-to-head trials between treatments.
PubMed 36980446Comparing dextrose injection volumes
Randomized double-blinded three-arm trial (Lin et al., Front Pharmacol 2020, n=63 wrists) compared 1 ml, 2 ml, and 4 ml of 5% dextrose for CTS. The 4 ml arm produced superior reductions in Boston Carpal Tunnel Questionnaire symptom severity and functional status scores at weeks 1, 4, and 12; by week 24 the three groups were similar. Results support higher injection volume as a meaningful technical variable in nerve hydrodissection.
PubMed 33391002Dextrose outperforms saline placebo through six months
Prospective randomized double-blind placebo-controlled trial (Wu et al., Mayo Clin Proc 2017, 49 participants, 60 wrists) compared 5% dextrose perineural injection to normal saline for mild-to-moderate carpal tunnel syndrome. At all follow-up points through 6 months, the dextrose group showed significantly greater improvement in pain, symptom severity, functional status, nerve conduction velocity, and median nerve cross-sectional area. The first high-quality placebo-controlled RCT to demonstrate dextrose superior to saline for CTS.
PubMed 28778254Dextrose vs corticosteroid: randomized double-blind trial with neural imaging
Randomized double-blind trial (Wu et al., Ann Neurol 2018, 54 wrists, 27 per group) compared a single ultrasound-guided injection of 5% dextrose with triamcinolone for mild-to-moderate CTS. Both groups improved early, but the dextrose group had significantly greater reductions in pain and disability from months 4 through 6.
PubMed 30187524Dextrose and corticosteroid comparable over 12 months
Randomized trial (Muscle Nerve 2026, 57 patients, 114 hands) compared ultrasound-guided 5% dextrose with corticosteroid injection in bilateral mild-to-moderate CTS. Both improved symptoms, with the greatest benefit in the first three months. Clinically meaningful improvement was seen in about half of hands in both groups at 1 and 3 months, falling to 29% (dextrose) and 25% (corticosteroid) at 12 months, with no significant difference between treatments.
PubMed 42206562Hydrodissection for persistent symptoms after carpal tunnel surgery
Retrospective study (Chao et al., J Clin Med 2022) evaluated dextrose hydrodissection in patients with persistent or recurrent CTS after primary surgical release — a population with limited treatment options. About 61% reported an effective outcome after an average of 3 injections, with benefit holding over a mean follow-up of nearly 3 years. As a retrospective study without a control group, it supports hydrodissection as a reasonable option after surgery rather than proving it.
PubMed 35806998Carpal Tunnel Syndrome Treatment: Common Questions
How is hydrodissection different from a cortisone injection for carpal tunnel?
They describe different things. Cortisone is a medication; hydrodissection is a technique that places fluid around the median nerve under ultrasound to separate it from surrounding tissue. The fluid used can vary — it may be 5% dextrose, saline, or a corticosteroid. In trials, dextrose and corticosteroid have produced broadly similar results over a year, with differences at some time points. If symptoms return after a cortisone injection, Dr. Borys reviews the exam and ultrasound findings to decide which option, if any, fits next.
Is hydrodissection an alternative to carpal tunnel surgery?
For many patients with mild-to-moderate carpal tunnel syndrome, yes — hydrodissection offers a non-surgical option with RCT support. There is also limited clinical evidence suggesting benefit in selected patients with persistent symptoms after surgical release. For severe CTS with significant thenar muscle wasting or advanced axonal loss on nerve conduction study, surgical release is generally the more appropriate intervention and Dr. Borys will say so clearly at the visit.
How many injections are typically needed?
Response varies by severity and duration of compression. Some patients experience significant improvement after a single session. Others benefit from two or three sessions spaced several weeks apart. The number of sessions will depend on your response and will be discussed after the initial evaluation.
Does Dr. Borys use ultrasound for the injection?
Yes. Ultrasound lets Dr. Borys see the median nerve and surrounding structures in real time, help identify the site of compression, and guide needle placement so fluid is delivered around the nerve. It lowers the risk of nerve contact but does not eliminate it.
My nerve conduction study was normal but my symptoms are consistent with carpal tunnel. Can hydrodissection still help?
Nerve conduction studies can be normal in early or mild carpal tunnel syndrome. Clinical diagnosis — based on symptom pattern, physical examination, and ultrasound assessment of median nerve cross-sectional area — can support a carpal tunnel diagnosis even when electrodiagnostics are equivocal. Dr. Borys will review your history, exam findings, and any available studies before recommending treatment.
The information on this page is for general educational purposes only and is not individual medical advice. It is not a substitute for a consultation with a qualified provider. Whether a treatment is appropriate depends on your individual evaluation, and individual results vary.